Frequently Asked Questions Common symptoms include persistent fatigue, weakness, pale skin, pins and needles, a sore tongue and cognitive difficulties such as brain fog or memory problems
FDA PCAC 2023 What this means practically for research dosage decisions: Doses above 1 mg/day are not supported by efficacy data and appear to produce diminishing returns
Information here is drawn from the published trial record, FDA regulatory documents, and animal studies
Route-Specific Pharmacokinetics: Intravenous Route:Peak plasma levels of cyanocobalamin are attained within 1 hour for parenteral doses
IV Infusions, Injections and Energy Sauna treatments are now HSA/FSA Eligible
Administration methods include intramuscular (IM) and intravenous (IV) injections